Rhabdomyosarcoma - Pipeline Review, H2 2015, New Report Launched
Rhabdomyosarcoma - Pipeline Review, H2 2015 report provides comprehensive information on the therapeutic development for Rhabdomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rhabdomyosarcoma and special features on late-stage and discontinued projects.
View full press release